Pancreatic Cancer

Knowledge is power. Are you facing a new diagnosis or recurrence of Pancreatic Cancer? The GI Connection Pancreatic Cancer Information Center has current, evidence-based information for you. Get the facts about the prevention, treatment, and living with Pancreatic Cancer. Stay up to date with news, tips, and features designed to keep you informed about the most recent developments and advances. Learn more about Pancreatic Cancer.

The GI Connection Pancreatic Cancer Community & Discussions

You are not alone—The GI Connection Community is the leading Social Media Application for individuals seeking information, inspiration, and support. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs. Login or register here.

PANCREATIC CANCER NEWS TIPS & FEATURES

April 18, 2018

First Interim Analysis in SEQUOIA Phase 3 Pancreatic Cancer Study

By Anonymous User anonymous_user_10987

CancerConnect News: The first interim analysis of the SEQUOIA clinical study evaluating the novel immunotherapy drug pegilodecakin in patients with […]

View full entry

Tags: AM0010, clinical trials, immunotherapy, Interleukin-10, News Tips and Features, News Tips and Features Other, Pancreatic Cancer, pegilodecakin, Precision Cancer Medicine, treatment


Pamrevlumab Awarded “Fast Track” Development Status for Treatment of Patients with Locally Advanced Pancreatic Cancer

March 5, 2018

Pamrevlumab Awarded “Fast Track” Development Status for Treatment of Patients with Locally Advanced Pancreatic Cancer

By Anonymous User anonymous_user_10987

CancerConnect News: The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the anti-CTGF antibody, pamrevlumab, for […]

View full entry

Tags: locally advanced, News Tips and Features, News Tips and Features Other, Pamrevlumab, Pancreatic Cancer, Precision Cancer Medicine, treatment


Larotrectinib Demonstrates 76 Percent Response Rate in TRK Fusion Cancers Including Pancreatic Cancer

February 28, 2018

Larotrectinib Demonstrates 76 Percent Response Rate in TRK Fusion Cancers Including Pancreatic Cancer

By Anonymous User anonymous_user_10987

CancerConnect News: Clinical data from three ongoing larotrectinib (LOXO-101) clinical trials in patients whose tumors harbor tropomyosin receptor kinase (TRK) […]

View full entry

Tags: larotrectinib, News Tips and Features, News Tips and Features Other, Pancreatic Cancer, Precision Cancer Medicine, treatment


A Global Phase 3 Study Investigating Cancer Stemness Inhibitor Napabucasin in Patients With Metastatic Pancreatic Cancer

August 15, 2017

A Global Phase 3 Study Investigating Cancer Stemness Inhibitor Napabucasin in Patients With Metastatic Pancreatic Cancer

By cancerconnect cancerconnect

A new clinical study will investigate napabucasin – an orally administered investigational agent designed to inhibit cancer stemness pathways by […]

View full entry

Tags: Cancer Stemness Inhibitor Napabucasin, clinical trial, News Tips and Features, News Tips and Features Other, Pancreatic Cancer


Clinical Data on Immunotherapy AM0010 in Advanced Pancreatic Cancer Promising

July 11, 2017

Clinical Data on Immunotherapy AM0010 in Advanced Pancreatic Cancer Promising

By Anonymous User anonymous_user_10987

ARMO BioSciences, Inc., a late-stage immuno-oncology company, announced clinical data on its lead investigational immuno-oncology drug AM0010 (pegilodecakin, PEGylated Interleukin-10) at […]

View full entry

Tags: AM0010, immunotherapy, Interleukin-10, News Tips and Features, News Tips and Features Other, Pancreatic Cancer, pegilodecakin


Preliminary Results Suggest That Pamrevlumab is Promising in Pancreatic Cancer

March 2, 2017

Preliminary Results Suggest That Pamrevlumab is Promising in Pancreatic Cancer

By Anonymous User anonymous_user_10987

Updated results from an ongoing clinical study of pamrevlumab (FG-3019) in combination with standard-of-care chemotherapy in patients with locally advanced […]

View full entry

Tags: connective tissue growth factor, News Tips and Features, News Tips and Features Other, Pamrevlumab. FG-3019, Pancreatic Cancer


Proton beam therapy may improve outcomes for pancreatic cancer

February 17, 2017

Proton beam therapy may improve outcomes for pancreatic cancer

By Anonymous User anonymous_user_10987

Currently a standard treatment for several gastrointestinal cancers (GI) combines the use of chemotherapy and radiation followed by surgical resection. […]

View full entry

Tags: News Tips and Features, News Tips and Features Other, Pancreatic Cancer, radiation


More News →

CONDITIONS OF THE GI TRACT